RxDoctor Payments Data

Peter Park, DO

Pain Medicine · Olympia, WANPI 1831650043

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.6%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medtronic at 38.1% of the total. Reporting peaked in 2023 at $9,272 and has fallen 54.0% since, to $4,262 in 2025. Among pain medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,082in general payments, 2019–2025

Across 144 payments — averaging $132.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Boston Scientific$5K
  • Abbott$3K
  • Nevro Corp.$2K
  • Globus Medical$1K
  • MML US, Inc.$643
  • plus $982 from 7 others

What the payments were for

  • Grants$6,00031%
  • Travel & lodging$3,42318%
  • Food & beverage$8,89247%
  • Education$7674%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,082 in reported general payments places this provider in the 90th percentile of 124 pain medicine providers in Washington.

See all pain medicine providers in Washington

Medicare billing

Part B allowed, 2024
$192,438
Medicare patients
504
Services billed
14,640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin132$2,872
Baclofen30$896
Methocarbamol36$786
Duloxetine Hcl45$545
Pregabalin25$402
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$321
Tizanidine Hcl22$272
Topiramate21$255
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$187
Cyclobenzaprine Hcl26$178
Meloxicam56$166
Methylprednisolone18$138
Diazepam23$26

Paid to pharmacies, not to this prescriber.

Other pain medicine in Olympia

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →